Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
5.88
+0.04 (0.68%)
May 13, 2025, 4:00 PM - Market closed
Emergent BioSolutions Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -131.6 | -190.6 | -760.5 | -211.6 | 219.5 | 305.8 | Upgrade
|
| Depreciation & Amortization | 106.3 | 108.8 | 125.1 | 130.6 | 123.8 | 114.5 | Upgrade
|
| Other Amortization | 2.8 | 7.4 | 21.3 | 4.1 | 4.1 | 3.5 | Upgrade
|
| Loss (Gain) From Sale of Assets | 9 | -3.5 | -53.1 | 3.6 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 27.2 | 27.2 | 524.9 | 19.4 | 41.7 | 29 | Upgrade
|
| Stock-Based Compensation | 13.6 | 18 | 23.1 | 45.1 | 42.4 | 51.8 | Upgrade
|
| Other Operating Activities | 15.3 | 2.7 | -16.8 | -23.2 | 33.7 | 22.8 | Upgrade
|
| Change in Accounts Receivable | -47.7 | -24.4 | -21.6 | 118.1 | -16.2 | 27.5 | Upgrade
|
| Change in Inventory | -22.2 | -24.5 | 0.6 | -57.1 | -66.6 | -66.9 | Upgrade
|
| Change in Accounts Payable | -36 | -33 | 10.6 | -14 | -1.6 | 28.3 | Upgrade
|
| Change in Unearned Revenue | -0.9 | -20.3 | 5.9 | 9.6 | -31.8 | 11.2 | Upgrade
|
| Change in Income Taxes | -1.2 | 23.3 | -16.2 | 28.7 | -31.3 | 6 | Upgrade
|
| Change in Other Net Operating Assets | 175.5 | 167.6 | -49.6 | -87.4 | 2.5 | 3.4 | Upgrade
|
| Operating Cash Flow | 110.1 | 58.7 | -206.3 | -34.1 | 320.2 | 536.9 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -40.36% | 185.59% | Upgrade
|
| Capital Expenditures | -15.7 | -22.9 | -51.6 | -115.8 | -224.1 | -141.9 | Upgrade
|
| Sale of Property, Plant & Equipment | 46 | 7.9 | - | - | - | - | Upgrade
|
| Divestitures | 110.2 | 110.2 | 270.2 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | 60 | 30 | -6.3 | -243.7 | - | -10 | Upgrade
|
| Other Investing Activities | -5 | - | - | -21.8 | - | - | Upgrade
|
| Investing Cash Flow | 195.5 | 125.2 | 212.3 | -381.3 | -224.1 | -151.9 | Upgrade
|
| Long-Term Debt Issued | - | 284 | 20 | 598 | - | 450 | Upgrade
|
| Long-Term Debt Repaid | - | -482.4 | -563.4 | -33.8 | -35.9 | -387.1 | Upgrade
|
| Total Debt Repaid | -473.5 | -482.4 | -563.4 | -33.8 | -35.9 | -387.1 | Upgrade
|
| Net Debt Issued (Repaid) | -239.5 | -198.4 | -543.4 | 564.2 | -35.9 | 62.9 | Upgrade
|
| Issuance of Common Stock | 10.9 | 10.8 | 10.2 | 5 | 15.9 | 31.6 | Upgrade
|
| Repurchase of Common Stock | -1.3 | -1.2 | -2.5 | -88 | -119.8 | -13.8 | Upgrade
|
| Other Financing Activities | -1.2 | -1.2 | - | - | -1.2 | -11.2 | Upgrade
|
| Financing Cash Flow | -231.1 | -190 | -535.7 | 481.2 | -141 | 69.5 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.7 | - | -1.2 | 0.5 | -0.3 | -1 | Upgrade
|
| Net Cash Flow | 73.8 | -6.1 | -530.9 | 66.3 | -45.2 | 453.5 | Upgrade
|
| Free Cash Flow | 94.4 | 35.8 | -257.9 | -149.9 | 96.1 | 395 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -75.67% | 290.70% | Upgrade
|
| Free Cash Flow Margin | 9.78% | 3.43% | -24.58% | -13.41% | 5.42% | 25.04% | Upgrade
|
| Free Cash Flow Per Share | 1.76 | 0.68 | -5.04 | -2.99 | 1.78 | 7.34 | Upgrade
|
| Cash Interest Paid | 59.2 | 64 | 68.3 | 33 | 30.4 | 21 | Upgrade
|
| Cash Income Tax Paid | 28.6 | 26.5 | 52.8 | 6.2 | 71.6 | 109.3 | Upgrade
|
| Levered Free Cash Flow | 97.11 | 58.5 | -88.6 | -203.13 | 39.19 | 393.94 | Upgrade
|
| Unlevered Free Cash Flow | 132.69 | 95.48 | -54.96 | -183.91 | 56.65 | 410 | Upgrade
|
| Change in Net Working Capital | 9.6 | 5.8 | 40.2 | -68.2 | 126.7 | -83.6 | Upgrade
|
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.